Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

Also called NCT02490306

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Mikael Elam (from the registry)
Registry
  • NCT NCT02490306
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02490306. Non-randomized; no masking; primary purpose diagnostic. Start 2015-07 (registry gives no type); primary completion 2023-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating Use of Microwave Technology to Differentiate Hemorrhagic Stroke From Infarction in the Acute Phase
Condition
Stroke
Intervention (Device)
Strokefinder MD100 measurement
Lead sponsor
Mikael Elam (class: other)
Collaborator
Medfield Diagnostics (class: industry)
Collaborator
Chalmers University of Technology (class: other)

Record details

Record id
cardio:ct-nct02490306
Content hash
edd541feb40165fd9c12144b688335a7f2f69f1bc6a0fafa62bf751e01375ab4